Search - tctmd.com

Displaying 101 - 120 of 134

Sort: Relevancy | Date

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Presenter: Josep Rod?s-Cabau

May 20, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Yael L. Maxwell

June 28, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

Advertisement

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Hospital Volume Linked to More Favorable LAA Closure Outcomes

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Benefit of LAA Closure Becomes Most Evident After 1 Year

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content